📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Oil Tumbles 2nd Day in Row on OPEC, Delta Variant Concerns

Published 07/15/2021, 03:18 PM
Updated 07/15/2021, 03:20 PM
© Reuters.

By Barani Krishnan

Investing.com - Worries over what OPEC+ will do for August production and the likely impact of the Covid Delta variant in the coming months on oil demand sent crude prices down hard for a second day in a row Thursday.

A rebound in the dollar, the currency oil trades on, also pressured crude prices.

New York-traded West Texas Intermediate crude, the benchmark for U.S. oil, settled down $1.48, or 2%, at $71.65 a barrel. WTI lost 2.8% in the previous session.

London-traded Brent, the global benchmark for oil, fell $1.29, or 1.7%, to finish the session at $73.47. Brent lost 2.3% on Wednesday.

On the OPEC front, Saudi Arabia and the United Arab Emirates appeared to be closing in on an agreement on August production. But the deal still needs to be ratified by the enlarged 23-nation OPEC+ alliance that groups the 13-member Saudi-led Organization of the Petroleum Exporting Countries with 10 assorted producers led by Russia.

Goldman Sachs Group Inc (NYSE:GS). said an accord announced by OPEC+ would be a “bullish catalyst,” that removes the risk of a potential price war between the Saudis and the Emiratis. Even so, the deal could add meaningfully to the alliance’s output, with reports on Wednesday that even the Iraqis were seeking a larger hike, just like the UAE.

Separately, OPEC published its first detailed assessment of 2022, in which it forecast that global oil demand will steadily recover to surpass pre-pandemic levels in the second half of next year. However, it also pointed to a lull in the first quarter.

On the Covid front, vaccination rates are down and cases are on the rise, exacerbated by the more transmissible Delta variant -- and an expert says the key to winning the race against the spread is getting more Americans vaccinated.

"We're losing time here. The Delta variant is spreading, people are dying, we can't actually just wait for things to get more rational," Dr. Francis Collins, director of the National Institutes of Health told CNN Wednesday.

Vaccines have been available to most Americans for months, but still only 48.2% of the country is fully vaccinated, according to the U.S. Centers for Disease Control and Prevention -- and the rate of new vaccinations is on the decline.

Meanwhile, case rates have been going up dramatically. In 47 states, the rate of new cases in the past week are at least 10% higher than the previous week, according to data from Johns Hopkins University. Of those, 35 have seen increases of over 50%.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.